# Prednisolone for 12 Versus 6 Months to Treat Pulmonary Sarcoidosis

> **NCT06654934** · PHASE4 · NOT_YET_RECRUITING · sponsor: **Post Graduate Institute of Medical Education and Research, Chandigarh** · enrollment: 100 (estimated)

## Conditions studied

- Sarcoidosis

## Interventions

- **DRUG:** Prednisolone
- **DRUG:** Prednisolone

## Key facts

- **NCT ID:** NCT06654934
- **Lead sponsor:** Post Graduate Institute of Medical Education and Research, Chandigarh
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2024-11
- **Primary completion:** 2026-12
- **Final completion:** 2026-12
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2024-10-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06654934

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06654934, "Prednisolone for 12 Versus 6 Months to Treat Pulmonary Sarcoidosis". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT06654934. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*